News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

The University of Manchester is looking for businesses active in the Drug Discovery and Advanced Therapeutics field to join a sandpit event aimed at fostering academic-industry collaboration...

Contracts worth over £500,000 with the potential for downstream milestone and royalty/ licensing payments

The University of Liverpool in partnership with the Liverpool School of Tropical Medicine have joined forces on a £1.3million research project to develop new inhaled drug delivery platforms...

Aptamer Group Limited, the developer of Optimer™ therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, today annou...

LSTM has received a grant of £3.3million of the European Regional Development Fund to improve the product development in the formulation of infectious diseases therapeutics.

Atelerix welcomes Steve Docksey as Executive Chair and Ed Wagena as Chief Operating Officer! Atelerix has significantly strengthened its leadership team with two experienced industry execut...

This test will omit the need for lab-based PCR testing for the virus antigen, massively scaling up the number of SARS Cov-2 virus tests that can be conducted in a community setting, partner...

Funding available for the development and testing of therapeutics to treat COVID-19.

The European Innovative Medicines Initiative will launch a call for applications to address the Corona virus in early March

Blueberry Therapeutics has received an investigational new drug (IND) clearance from the Food and Drug Administration (FDA) to proceed with the clinical development of BB2603 for the treatme...

Alderley Park, United Kingdom — BiVictriX announces today that Dr Michael Carter has joined its board as a Non-executive Director, and that it has completed an internal fund-raising round ...

Blueberry Therapeutics Limited, a modern drug discovery and development company committed to the development of innovative new therapies for the treatment of common and difficult to treat de...

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners